Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Robinson

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Lung Cancer|January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line TherapyOmar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JTO Clinical and Research Reports|August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLCOmar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
JCO Oncology Practice|May 23, 2023
On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black VeteransJeffrey W Shevach, Lisa B Aiello, Julie A Lynch, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Zebrafish|April 18, 2013
Towards a comprehensive catalog of zebrafish behavior 1.0 and beyondAllan V Kalueff, Michael Gebhardt, Adam Michael Stewart, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Lung Cancer|January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line TherapyOmar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JTO Clinical and Research Reports|August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLCOmar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
JCO Oncology Practice|May 23, 2023
On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black VeteransJeffrey W Shevach, Lisa B Aiello, Julie A Lynch, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Zebrafish|April 18, 2013
Towards a comprehensive catalog of zebrafish behavior 1.0 and beyondAllan V Kalueff, Michael Gebhardt, Adam Michael Stewart, et al.
Pageof 3